Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Molecular Cytogenetics|August 8, 2020
13q deletion syndrome resulting from balanced chromosomal rearrangement in father: the significance of parental karyotypingSabine Dittner-Moormann, Madlen Reschke, Eva Biewald, et al.
Klinische Monatsblatter Fur Augenheilkunde|August 10, 2021
Intraarterial Chemotherapy for Retinoblastoma - Initial Experiences of a German Reference CentreTobias Kiefer, Sabrina Schlüter, Nikolaos E Bechrakis, et al.
Klinische Monatsblatter Fur Augenheilkunde|August 10, 2021
Brachytherapy for Peripheral Retinal Capillary Haemangioblastoma in von Hippel-Lindau DiseaseSami Dalbah, Nikolaos E Bechrakis, Henning Thomasen, et al.
Pediatric Blood & Cancer|April 2, 2026
MYCN Amplification in RB1-Inactivated Retinoblastoma: Association With High-Risk FeaturesKyriaki Papaioannou, Regina Kubica, Karen Fischhuber, et al.
Pediatric Hematology and Oncology|August 4, 2015
Pediatric Survivors of Retinoblastoma Are at Risk for Altered Bone Metabolism After Chemotherapy Treatment Early in LifeMichael M Schündeln, Pia K Hauffa, Jens J Bauer, et al.
Frontiers in Oncology|November 15, 2023
PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastomaKarim Al-Ghazzawi, Michael Wessolly, Sami Dalbah, et al.
Ocular Oncology and Pathology|October 2, 2020
Long-Term Clinical Results and Management following Vitrectomy in Undetected Retinoblastoma EyesEva Biewald, Sabrina Schlüter, Nikolaos E Bechrakis, et al.
Cancers|February 15, 2022
TFF1 in Aqueous Humor-A Potential New Biomarker for RetinoblastomaMaike Anna Busch, André Haase, Natalia Miroschnikov, et al.
Clinical & Experimental Ophthalmology|April 18, 2021
Scleral necrosis after brachytherapy for uveal melanoma: Analysis of risk factorsLeyla Jabbarli, Maja Guberina, Eva Biewald, et al.
International Journal of Molecular Sciences|October 27, 2022
ADAM10 and ADAM17-Novel Players in Retinoblastoma CarcinogenesisDario Van Meenen, Annika Doege, Emily Alefeld, et al.
Pageof 5